FRMSL (4746.TW) monthly revenue, September 2026

FRMSL reported revenue of NT$0.49bn for September 2026, up 6.3% from the previous month and up 17.2% from a year earlier. Year-to-date revenue was NT$3.51bn, down 1.0% year on year. It ranked 60 of 159 companies in the Biotechnology and Medical Care industry by year-on-year growth.

中文版

MonthRevenue NT$bnMoM %YoY %
September 20260.496.317.2